Ping Li

Dr. Ping Li

Auto-generated profile, based on publicly available information

Dr. Ping Li


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2020 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JLJing-Ru Liu
Jing-Ru Liu
HMHua Miao
Hua Miao
DDDe-Qiang Deng
De-Qiang Deng
NVNosratola D. Vaziri
Nosratola D. Vaziri
PLPing Li
Ping Li
Ying-Yong ZhaoYing-Yong Zhao
Ying-Yong Zhao

1 January 2023 in Aging and disease
Verified
Journal Article
Open access
PDF file
LRLi-Li Ren
Li-Li Ren
HMHua Miao
Hua Miao
YWYan-Ni Wang
Yan-Ni Wang
FLFei Liu
Fei Liu
PLPing Li
Ping Li
Ying-Yong ZhaoYing-Yong Zhao
Ying-Yong Zhao
Fibrosis is the abnormal accumulation of extracellular matrix proteins such as collagen and fibronectin. Aging, injury, infections, and inflammation can cause different types of tissue fibrosis. Numerous clinical investigations have shown a correlation between the degree of liver and pulmonary fibrosis in patients and telomere length and mitochondrial DNA content, both of which are signs of aging. Aging involves the gradual loss of tissue function over time, which results in the loss of homeostasis and, ultimately, an organism's fitness. A major feature of aging is the accumulation of senescent cells. Senescent cells abnormally and continuously accumulate in the late stages of life, contributing to age-related fibrosis and tissue deterioration, among other aging characteristics. Furthermore, aging generates chronic inflammation, which results in fibrosis and decreases organ function. This finding suggests that fibrosis and aging are closely related. The transforming growth factor-beta (TGF-β) superfamily plays a crucial role in the physiological and pathological processes of aging, immune regulation, atherosclerosis, and tissue fibrosis. In this review, the functions of TGF-β in normal organs, aging, and fibrotic tissues is discussed: TGF-β signalling is altered with age and is an indicator of pathology associated with tissue fibrosis. In addition, this review discusses the potential targeting of noncoding.

16 May 2022 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
GCGang Cao
Gang Cao
HMHua Miao
Hua Miao
YWYan-Ni Wang
Yan-Ni Wang
DCDan-Qian Chen
Dan-Qian Chen
XWXia-Qing Wu
Xia-Qing Wu
Ying-Yong ZhaoYing-Yong Zhao
Ying-Yong Zhao

4 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PLPing Li
Ping Li
YCYiping Chen
Yiping Chen
JLJianping Liu
Jianping Liu
JHJing Hong
Jing Hong
YDYueyi Deng
Yueyi Deng
WYWenying Yang
Wenying Yang
Persons with diabetes are at high risk of developing diabetic kidney disease (DKD), which is associated with high morbidity and mortality. Current drug therapies for DKD, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are not entirely satisfactory. This study aimed to evaluate the additional benefit and safety of the Chinese herbal granule Tangshen Formula (TSF) in treating DKD. The study was designed as a six-center randomized, double-blind, placebo-controlled trial. From April 2007 through December 2009, 180 patients with DKD were enrolled. In addition to conventional treatment with ACEIs or ARBs, 122 participants were randomly assigned to receive TSF and 58 participants to receive placebo for 24 weeks. Primary outcome was urinary protein level, measured by urinary albumin excretion rate (UAER) for participants with microalbuminuria, 24-hour urinary protein (24h UP) for participants with macroalbuminuria. Secondary outcomes included renal function, serum lipids, quality of life, symptoms, and adverse events. After 24 weeks of treatment, no statistically significant difference in UAER (TSF −19.53 μg/min compared with placebo −7.01 μg/min, with a mean difference of −12.52 μg/min; 95%CI, −68.67 to 43.63, P = 0.696) was found between TSF and placebo groups. However, TSF displayed a statistically significant decrease in 24h UP (TSF−0.21 g compared with placebo 0.36 g, with a mean difference of −0.57g; 95%CI, −1.05 to −0.09, P = 0.024). Estimated glomerular filtration rate (eGFR) was improved in both patients with microalbuminuria and macroalbuminuria, with a mean difference of 15.51 ml/min/1.73 m2 (95%CI, 3.71 to 27.31), 9.01 ml/min/1.73 m2 (95%CI, −0.10 to 18.13), respectively. Other secondary outcomes showed no statistically significant difference between groups or in the incidence of adverse events. Based on conventional treatments, TSF appears to provide additional benefits compared with placebo in decreasing proteinuria and improving eGFR in DKD patients with macroalbuminuria. Nevertheless, further study is needed to evaluate TSF treating patients with microalbuminuria. Chinese Clinical Trial Registry ChiCTR-TRC-10000843

23 June 2025 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
HMHua Miao
Hua Miao
SZShui-Juan Zhang
Shui-Juan Zhang
XWXin Wu
Xin Wu
PLPing Li
Ping Li
Ying-Yong ZhaoYing-Yong Zhao
Ying-Yong Zhao
Aromatic amino acid tryptophan metabolism, particularly three main metabolism pathways including kynurenine, serotonin and indole-derived pathways are under the direct or indirect modulation of host-microbiota crosstalk in human physiology. Tryptophan metabolism is involved in the regulation of aging, immunity and intestinal homeostasis. Dysregulation of tryptophan metabolism ranging from bowel disease to kidney disease allow us to therapeutic targeting the tryptophan metabolism. This review summarizes recent advances in physiological and pathophysiological roles of tryptophan metabolism in health and disease such as ageing-related disease, bowel disease and renal disease. Decoding the sophisticated imbalance between tryptophan metabolism pathways will expedite a comprehensive understanding of the pathogenesis of human diseases and highlight the opportunities and challenges for medication research and development in multiple diseases. This review presents concept-driven diagnostic and therapeutic strategies for the management of patients with kidney disease by gut-kidney-aging axes.

1 January 2024 in International Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
YWYing Wang
Ying Wang
TLTongtong Liu
Tongtong Liu
YWYun Wu
Yun Wu
LWLin Wang
Lin Wang
SDShaowei Ding
Shaowei Ding
PLPing Li
Ping Li
Lipid homeostasis is crucial for proper cellular and systemic functions. A growing number of studies confirm the importance of lipid homeostasis in diabetic kidney disease (DKD). Lipotoxicity caused by imbalance in renal lipid homeostasis can further exasperate renal injury. Large lipid deposits and lipid droplet accumulation are present in the kidneys of DKD patients. Autophagy plays a critical role in DKD lipid homeostasis and is involved in the regulation of lipid content. Inhibition or reduction of autophagy can lead to lipid accumulation, which in turn further affects autophagy. Lipophagy selectively recognizes and degrades lipids and helps to regulate cellular lipid metabolism and maintain intracellular lipid homeostasis. Therefore, we provide a systematic review of fatty acid, cholesterol, and sphingolipid metabolism, and discuss the responses of different renal intrinsic cells to imbalances in lipid homeostasis. Finally, we discuss the mechanism by which autophagy, especially lipophagy, maintains lipid homeostasis to support the development of new DKD drugs targeting lipid homeostasis.